Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The cost of unresectable stage III or stage IV melanoma in Italy.
Maio M, Ascierto P, Testori A, Ridolfi R, Bajetta E, Queirolo P, Guida M, Romanini A, Chiarion-Sileni V, Pigozzo J, Di Giacomo AM, Calandriello M, Didoni G, van Baardewijk M, Konto C, Lucioni C. Maio M, et al. J Exp Clin Cancer Res. 2012 Nov 1;31(1):91. doi: 10.1186/1756-9966-31-91. J Exp Clin Cancer Res. 2012. PMID: 23116062 Free PMC article.
Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial.
Ridolfi R, Chiarion-Sileni V, Guida M, Romanini A, Labianca R, Freschi A, Lo Re G, Nortilli R, Brugnara S, Vitali P, Nanni O; Italian Melanoma Intergroup. Ridolfi R, et al. J Clin Oncol. 2002 Mar 15;20(6):1600-7. doi: 10.1200/JCO.2002.20.6.1600. J Clin Oncol. 2002. PMID: 11896110 Clinical Trial.
Brain metastases from malignant melanoma.
Chiarion-Sileni V, Murr R, Pigozzo J, Sarti S, Tomassi O, Romanini A. Chiarion-Sileni V, et al. Forum (Genova). 2003;13(2):170-82; quiz 190. Forum (Genova). 2003. PMID: 14732883 Review.
Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874].
Chiarion-Sileni V, Del Bianco P, Romanini A, Guida M, Paccagnella A, Dalla Palma M, Naglieri E, Ridolfi R, Silvestri B, Michiara M, De Salvo GL. Chiarion-Sileni V, et al. BMC Cancer. 2006 Feb 27;6:44. doi: 10.1186/1471-2407-6-44. BMC Cancer. 2006. PMID: 16504154 Free PMC article. Clinical Trial.
Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.
Guida M, Riccobon A, Biasco G, Ravaioli A, Casamassima A, Freschi A, Palma MD, Galligioni E, Nortilli R, Chiarion-Sileni V, Picozzo J, Romanini A, Nanni O, Ridolfi R; Italian Melanoma Intergroup (IMI). Guida M, et al. Melanoma Res. 2006 Aug;16(4):317-23. doi: 10.1097/01.cmr.0000200491.00841.5f. Melanoma Res. 2006. PMID: 16845327 Clinical Trial.
Surgery and radiotherapy in the treatment of cutaneous melanoma.
Testori A, Rutkowski P, Marsden J, Bastholt L, Chiarion-Sileni V, Hauschild A, Eggermont AM. Testori A, et al. Ann Oncol. 2009 Aug;20 Suppl 6(Suppl 6):vi22-9. doi: 10.1093/annonc/mdp257. Ann Oncol. 2009. PMID: 19617294 Free PMC article. Review.
216 results